Early research (Phase 1)Ended earlyNCT04691375What this trial is testingPY314 in Subjects With Advanced Solid TumorsWho this might be right forAdvanced Solid TumorGynecologic CancerBreast Cancer+6 more Ikena Oncology 86
Early research (Phase 1)Study completedNCT03538028What this trial is testingA Safety and Tolerability Study of INCAGN02385 in Select Advanced MalignanciesWho this might be right forCervical CancerMicrosatellite Instability (MSI)-High Endometrial CancerGastric Cancer (Including Stomach and Gastroesophageal Junction [GEJ])+14 more Incyte Biosciences International Sàrl 22
Early research (Phase 1)UnknownNCT05369312What this trial is testingPhase 1 Study of BPI-442096 in Advanced Solid Tumor PatientsWho this might be right forSolid TumorNon-small Cell Lung CancerPancreatic Cancer+1 more Betta Pharmaceuticals Co., Ltd. 230
Testing effectiveness (Phase 2)Looking for participantsNCT07070232What this trial is testingA Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant TumorsWho this might be right forAdvanced Solid Tumor BioNTech SE 1,438
Testing effectiveness (Phase 2)UnknownNCT04903873What this trial is testingEvaluate Safety, Efficacy, and Pharmacokinetics in Participants With Advanced Solid TumorsWho this might be right forSolid TumorRenal Cell Cancer MetastaticNon-Small Cell Lung Cancer+2 more Eutilex 110
Early research (Phase 1)Study completedNCT00471432What this trial is testingOGX-011 and Docetaxel in Treating Patients With Metastatic or Locally Recurrent Solid TumorsWho this might be right forBladder CancerBreast CancerKidney Cancer+4 more NCIC Clinical Trials Group 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT03647163What this trial is testingPh I/II Trial of Systemic VSV-IFNβ-NIS in Combination With Checkpoint Inhibitor Therapy in Patients With Select Solid TumorsWho this might be right forSolid TumorNon Small Cell Lung CancerNeuroendocrine Carcinoma+1 more Vyriad, Inc. 33
Testing effectiveness (Phase 2)Looking for participantsNCT07670312What this trial is testingEvaluation of XYA02 in Patients With Advanced Solid TumorsWho this might be right forMUC1-expressing Advanced, Relapsed and/or Refractory Solid TumorsNon-Small Cell Lung CancerOvarian Cancer+4 more XYone Therapeutics, Inc 190
Early research (Phase 1)Study completedNCT01460134What this trial is testingCDX-1127 (Varlilumab) in Patients With Select Solid Tumor Types or Hematologic CancersWho this might be right forCD27 Expressing B-cell Malignancies for Example Hodgkin's LymphomaChronic Lymphocytic LeukemiaMantle Cell Lymphoma+7 more Celldex Therapeutics 90
Testing effectiveness (Phase 2)Study completedNCT04172506What this trial is testingEvaluate the Efficacy and Safety of Anti-PD-1 Antibody AK105 in Patients With Selected Advanced Solid TumorsWho this might be right forSolid TumorLung CancerHCC Akeso 65
Not applicableActive Not RecruitingNCT05215769What this trial is testingA Video Intervention to Improve Patient Understanding of Tumor Genomic Testing in Patients With Metastatic CancerWho this might be right forAnatomic Stage IV Breast Cancer AJCC v8Metastatic Breast CarcinomaMetastatic Lung Carcinoma+5 more Ohio State University Comprehensive Cancer Center 243
Early research (Phase 1)Study completedNCT04855929What this trial is testingA Study Evaluating Safety and Therapeutic Activity of ANV419 in Patients with Advanced Cancer.Who this might be right forAdvanced Solid TumorAdult DiseaseLung Cancer Anaveon AG 55
Early research (Phase 1)Looking for participantsNCT06400472What this trial is testingSofe-M in Participants With Selected Advanced Solid TumorsWho this might be right forOvarian NeoplasmsEndometrial NeoplasmsUterine Cervical Neoplasms+4 more Eli Lilly and Company 575
Early research (Phase 1)Looking for participantsNCT06266299What this trial is testingKK2269 in Adult Participants With Solid TumorsWho this might be right forAdvanced Solid TumorMetastatic Solid TumorGastric Adenocarcinoma+3 more Kyowa Kirin Co., Ltd. 101
Early research (Phase 1)Ended earlyNCT06264921What this trial is testingA Study With NKT3447 for Adults With Advanced/Metastatic Solid TumorsWho this might be right forSolid TumorSolid Tumor, AdultAdvanced Solid Tumor+26 more NiKang Therapeutics, Inc. 23
Testing effectiveness (Phase 2)Active Not RecruitingNCT05128487What this trial is testingNDI 1150-101 in Patients With Solid TumorsWho this might be right forSolid TumorRenal Cell Carcinoma (Kidney Cancer)Gastric and Gastroesophageal Junction (GEJ) Adenocarcinoma+1 more Nimbus Saturn, Inc. 106
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06724263What this trial is testingA Multicenter, Open-label Phase IIa Clinical Study to Evaluate the Efficacy and Safety of B1962 Injection in the Treatment of Advanced Malignant Solid TumorsWho this might be right forRecurrent Platinum-resistant Epithelial Ovarian CancerTriple Negative Breast Cancer (TNBC)Cervical Cancers+4 more Tasly Biopharmaceuticals Co., Ltd. 120
Early research (Phase 1)Looking for participantsNCT06673329What this trial is testingBrodalumab in the Treatment of Immune-Related Adverse EventsWho this might be right forBreast CancerEsophageal CancerKidney Cancer+15 more Brian Henick, MD 11
Early research (Phase 1)Ended earlyNCT04458259What this trial is testingStudy of PF-07265807 in Participants With Metastatic Solid Tumors.Who this might be right forNeoplasm Metastasis Pfizer 88
Testing effectiveness (Phase 2)Ended earlyNCT02712905What this trial is testingAn Open-Label, Dose-Escalation/Dose-Expansion Safety Study of INCB059872 in Subjects With Advanced MalignanciesWho this might be right forSolid Tumors and Hematologic Malignancy Incyte Corporation 116